US Stock MarketDetailed Quotes

Verrica Pharmaceuticals (VRCA)

Watchlist
  • 5.820
  • -0.205-3.40%
Trading Jun 12 14:15 ET
99.98MMarket Cap-5.29P/E (TTM)

Verrica Pharmaceuticals (VRCA) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q1
Stock NameRevenueRatio
Developing and commercializing medications for the treatment of dermatologic diseases, including5.02M100.00%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States35.58M100.00%
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran negotiations have entered a critical window! According to Bloomberg, both sides are close to signing a memorandum of understan Show More